Blogs
In rebuke to pharma, one-fifth of Bristol-Myers shareholders favor proposal tying pricing risks to executive pay
23% of Bristol Myers-Squibb shareholders back proposal about drug pricing, compensation
Gun safety activists prepare to put their power behind shareholder voting at Sturm Ruger
22% of Bristol-Myers Squibb shareholders favor report on how drug pricing risks are integrated into exec incentive programs
5 golden rules for investors on good governance and safer chemicals
Global investors call for apparel supply chain transparency
Proxy adviser ISS backs call for gun safety report at Sturm Ruger
The Bangladesh Garment Factory Workers Tragedy — and Investor and Corporate Response Five Years On
There’s No Smoking in Disney Films. What About When It Owns Fox?
Pages
